• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem High Test Results (2457)
Patient Problem Thromboembolism (2654)
Event Date 09/27/2022
Event Type  Injury  
Manufacturer Narrative
Occupation is patient/consumer.The reporter¿s meter and strips were provided for investigation where they were tested using retention controls.Testing results (qc range = 4.1 ¿ 6.8 inr): qc 1: 5.1 inr; qc 2: 5.2 inr; qc 3: 5.2 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.The results alleged by the customer were observed in the meter¿s patient result memory.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.
 
Event Description
There was an allegation that inr results from coaguchek inrange meter serial number (b)(4) may have contributed to the patient¿s admission to the hospital for low inr and treatment.The patient¿s therapeutic range at this time was reportedly 2.0 ¿ 3.0 inr.The patient¿s warfarin regimen at this time allegedly alternated between 8mg and 4 mg.The patient's testing frequency was reportedly originally planned for weekly but has changed to every "couple of days." on (b)(6) 2022 at 6:00 a.M.The meter result was reportedly 2.0 inr.On (b)(6) 2022 the patient allegedly stopped her warfarin dose and bridged with lovenox on (b)(6) 2022 in preparation for a procedure to fix the leakage around the mitral valve that was identified on a follow-up appointment from her open heart surgery that had been performed on (b)(6) 2022.On (b)(6) 2022 the patient reportedly went in for a transesophageal echocardiogram (tee) in preparation for the procedure.No leakage was found around the mitral valve but a blood clot was allegedly found.The result from an unknown laboratory method was reportedly 1.3 inr.The patient no longer needed the procedure, however, she was reportedly admitted to the hospital due to low inr.The patient was allegedly treated intravenously with a high-intensity heparin drip in addition to an unspecified dosage of warfarin.The patient was kept in the hospital until her inr was elevated.On (b)(6) 2022 the patient was discharged from the hospital with a reported lab result from an unknown method of 3.5 inr.Following this event, the patient¿s therapeutic range was changed to 3.0 ¿ 3.5 inr.The patient is currently in stable condition.This mdr is being submitted in an abundance of caution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key15770814
MDR Text Key303414293
Report Number1823260-2022-03576
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K170960
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/10/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date07/31/2023
Device Catalogue Number04625374160
Device Lot Number58526222
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/19/2022
Date Manufacturer Received10/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARMOUR THYROID; FERROUS GLUCONATE; GARDEN OF LIFE MULTI VITAMIN - LONG TERM USE; GARDEN OF LIFE PROBIOTIC; METOPROLOL TARTRATE; MIRALAX - EVERY 3 DAYS; NOW CALCIUM- MAGNESIUM; NOW VITAMIN D 5000IU; SERTRALINE; TORSEMIDE; TRAZODONE; WARFARIN
Patient Outcome(s) Hospitalization;
Patient Age59 YR
Patient SexFemale
-
-